|
|
Profile
|
Delegates :
Tomohiro Yamaguchi |
|
Incorporated :
August 5 , 2005 |
Paid in Capital :
5 Million yen |
Employees :
5 人 |
Address :
Noukoudai・Tamakoganei-Venture port 302 Naka-cho 2-24-16, Koganei-shi, Tokyo 184-0012 TOKYO
〒0840012
|
TEL/FAX :
+81-42-401-2291 / +81-42-382-7384 |
URL：
http://www.canine-lab.jp/ |
Attachment :
|
Mission/Background :
The life of the companion animals were prolonged by a change of the breeding environment, and was increased lifestyle-related diseases by the aging. We support that the companion animals receive appropriate treatment by the immunotherapy and a genetic test technology. In now, we are given inspection from animal hospitals in japan. In addition, we make use of these advanced technology and aim of the highly medical animal hospital administration at inspection, treatment and researching and developing. |
|
Technology & Business
|
The outline of a product, a technique and the service: The genetic test for companion animals, the technical service of the immunotherapy, and the development of the monoclonal antibody. We offer the immunotherapy technique as the method of the immune-potentiation for large animals (including a cow and the horse).
A business partner: We carry out universities and collaborative investigation of veterinarians such as Nihon Veterinary and animal Life science University, Obihiro University of Agriculture and Veterinary Medicine, Osaka Prefecture University and Kitasato University.
The situation of the intellectual property: We are applying for a patent on the immune- potentiator for the large animal which we applied cell-mediated immunotherapy (Patent Pending). And we are examining the international patent application.
The superiority of the service: Application of the cell-mediated immunotherapy for large animals is the first trial in the world at the point of the preventive veterinary medicine.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
Activated lymphocyte
|
Discovery
|
The new technology of immunopotentiation for large animals
|
Evaluation of the clinical effect and side effect. The choice of the business partner
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Highlights
|
“The development of the new technology of immunopotentiaton with the allogeneic activated lymphocyte for the large animal (a cow and horse) “ We stared Collaborative investigation with Kitasato University, it has been already established in the janapnese patent. In now, during present international patent application preparations (PCT applied). Including inside and outside the country, I look for business partner such as technical cooperation, the joint development.
|
|
Alliance strategy
|
The new technology of immunomodulation with the activated lymphocyte for large animals is the first trial in the world. We hope for collaborative investigation, technical derivation and the business tie-up including the license in japan or other countries. Particularly, I expect the tie-up with the company which is interested in development as cell-mediated pharmaceutical products.
|
|
|